Maynard Ryan D

Iovance Biotherapeutics, Inc. · Director

Maynard Ryan D is listed in filings as Director at Iovance Biotherapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 24, 2026, including sale activity. Recent filings connect the profile to Iovance Biotherapeutics, Inc. (IOVA) and Foghorn Therapeutics Inc. (FHTX). The current snapshot covers public activity from Jun 13, 2024 to Feb 24, 2026. Reported amounts are shown as $503.0K to $2.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.